BackBeximco Pharmaceuticals Limited Overview

Beximco Pharmaceuticals Limited Accounts Payable

Beximco Pharmaceuticals Limited's accounts payable is $2.1B.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$2.09B
↓ 36.07% YoYΔ $-1.18B vs prior year quarter

Peer trimmed avg / median

Loading

Beximco Pharmaceuticals Limited Accounts Payable History

Loading

Beximco Pharmaceuticals Limited vs. peers: Accounts Payable Comparison

Loading

Beximco Pharmaceuticals Limited Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Beximco Pharmaceuticals Limited (BXP.L) FAQ

As of the most recent data (March 2026), BXP.L shows a accounts payable of $2.1B. That compares with $3.3B in the prior-year period — down 36.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BXP.L's accounts payable is now $2.1B (was $3.3B) — a 36.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Beximco Pharmaceuticals Limited is outperforming or lagging.

Tracking BXP.L's accounts payable over time shows whether Beximco Pharmaceuticals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1B That compares with $3.3B in the prior-year period — down 36.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Beximco Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $2.1B) with ownership activity and broader fundamentals.